Pathway claimed that its Insight test could evaluate a propensity for developing medical conditions such as Alzheimer's disease, diabetes and obesity; the likelihood of parenting a baby with cystic fibrosis, Tay-Sachs and other genetic disorders; and the possible reaction to caffeine, cholesterol-lowering drugs, blood thinners and other medications.